Warning! GuruFocus detected
1 Severe warning sign
with PRCT.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
PROCEPT BioRobotics Corp
NAICS : 339112
SIC : 5047
ISIN : US74276L1052
Description
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.87 | |||||
| Equity-to-Asset | 0.75 | |||||
| Debt-to-Equity | 0.21 | |||||
| Debt-to-EBITDA | -1 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 12.38 | |||||
| Beneish M-Score | -1.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 27.2 | |||||
| 3-Year EBITDA Growth Rate | 20 | |||||
| 3-Year EPS without NRI Growth Rate | 21.7 | |||||
| 3-Year FCF Growth Rate | 17.3 | |||||
| 3-Year Book Growth Rate | 6.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 37.02 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 34.08 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.44 | |||||
| 9-Day RSI | 44.05 | |||||
| 14-Day RSI | 43.19 | |||||
| 3-1 Month Momentum % | -14.88 | |||||
| 6-1 Month Momentum % | -9.07 | |||||
| 12-1 Month Momentum % | 19.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.95 | |||||
| Quick Ratio | 7.75 | |||||
| Cash Ratio | 6.07 | |||||
| Days Inventory | 200.26 | |||||
| Days Sales Outstanding | 101.63 | |||||
| Days Payable | 47.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.8 | |||||
| Shareholder Yield % | -5.81 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.71 | |||||
| Operating Margin % | -38.7 | |||||
| Net Margin % | -36.2 | |||||
| FCF Margin % | -41.6 | |||||
| ROE % | -29.12 | |||||
| ROA % | -20.64 | |||||
| ROIC % | -57.66 | |||||
| 3-Year ROIIC % | -26.68 | |||||
| ROC (Joel Greenblatt) % | -67.32 | |||||
| ROCE % | -22.16 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 12.21 | |||||
| PB Ratio | 7.39 | |||||
| Price-to-Tangible-Book | 7.41 | |||||
| EV-to-EBIT | -30.71 | |||||
| EV-to-EBITDA | -32.23 | |||||
| EV-to-Revenue | 10.62 | |||||
| EV-to-Forward-Revenue | 29.31 | |||||
| EV-to-FCF | -25.54 | |||||
| Price-to-GF-Value | 0.52 | |||||
| Price-to-Net-Current-Asset-Value | 8.58 | |||||
| Price-to-Net-Cash | 15.48 | |||||
| Earnings Yield (Greenblatt) % | -3.26 | |||||
| FCF Yield % | -3.6 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PRCT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PROCEPT BioRobotics Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 249.121 | ||
| EPS (TTM) ($) | -1.7 | ||
| Beta | 1.04 | ||
| 3-Year Sharpe Ratio | 0.51 | ||
| 3-Year Sortino Ratio | 0.86 | ||
| Volatility % | 47.66 | ||
| 14-Day RSI | 43.19 | ||
| 14-Day ATR ($) | 3.770658 | ||
| 20-Day SMA ($) | 53.789 | ||
| 12-1 Month Momentum % | 19.61 | ||
| 52-Week Range ($) | 47.0401 - 103.8099 | ||
| Shares Outstanding (Mil) | 54.82 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PROCEPT BioRobotics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PROCEPT BioRobotics Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
PROCEPT BioRobotics Corp Frequently Asked Questions
What is PROCEPT BioRobotics Corp(PRCT)'s stock price today?
The current price of PRCT is $52.49. The 52 week high of PRCT is $103.81 and 52 week low is $47.04.
When is next earnings date of PROCEPT BioRobotics Corp(PRCT)?
The next earnings date of PROCEPT BioRobotics Corp(PRCT) is 2025-08-01 Est..
Does PROCEPT BioRobotics Corp(PRCT) pay dividends? If so, how much?
PROCEPT BioRobotics Corp(PRCT) does not pay dividend.
Guru Commentaries on NAS:PRCT
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers